Patients with a certain B-cell malignancy and abnormal liver function tests at diagnosis are at risk of shorter overall survival compared with those who have normal liver function. READ MORE
In a recent phase III trial, researchers compared the safety and efficacy of a maintenance therapy vs observation after ASCT in patients with a certain type of B-cell malignancy.
Progressive or relapsed Hodgkin lymphoma has demonstrated responsiveness to salvage radiotherapy in pediatric patients.
Radioactive iodine treatment for low-risk thyroid cancer is associated with nearly twice the risk of developing acute myeloid leukemia.
A recent study has shown that patients with relapsed or refractory chronic lymphocytic leukemia may prolong their progression-free survival after treatment with a specific combination regimen.
Research in Review
Consolidation with arsenic trioxide allows for decreased anthracycline dosing while maintaining survival rates and a low risk of relapse in pediatric patients with acute promyelocytic leukemia.
A recent study showed improved long-term survival outcomes and QoL for patients with MCL receiving TKI therapy compared with those receiving standard of care.
A weekly recap of trending news and research, including a special report on clinical pathways for advance stage gastric cancer and novel therapies for chronic lymphocytic leukemia.
Patients with chronic myeloid leukemia who attempt to discontinue tyrosine kinase inhibitor therapy for a second time after a first unsuccessful attempt have strong treatment-free remission rates.